OUR TASK

Antibiotic resistance is a global challenge

OUR TASK

The world is facing a major threat of antibiotic resistance. We aim to address this issue by transforming the way we detect infections with an innovative, fast and real-time technology.

THE CHALLENGE

For decades, laboratory technicians have relied upon crude and time-consuming techniques to diagnose infections, leaving physicians to guess which antibiotic therapy will be effective since reliable results often take days to develop. The increased presence of multi-drug resistant pathogens further aggravates the problem as more antibiotics fail to be effective.  Avails offers multiple products and solutions to mitigate this global health challenge.

OUR SOLUTION

The Avails technology platform is designed to significantly reduce the amount of time required to obtain the reliable antibiotic susceptibility data required to enable accurate therapy decisions.  Avails’ electronic biosensor technology is designed to improve accuracy in pathogen quantification and susceptibly testing directly from human specimens by eliminating crude, time-consuming culturing techniques.

AVAILS MEDICAL WILL TRANSFORM CURRENT PRACTICE